Millions of People Will Soon Be Blindsided. Will You Be One of Them?

On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X.

Tue, April 20 at 7:00PM ET
 
 
 
 

FDA Approves New Hot Flash Treatment for Menopause

prescription pills in bottles
Source: iStockphoto

The U.S. Food and Drug Administration has given the green light for Duavee, a drug made by Pfizer (PFE) and Ligand Pharmaceuticals (LGND), to hit the market. The treatment is designed to mitigate moderate-to-severe menopausal hot flashes in women who have not undergone a hysterectomy, Bloomberg notes.

Duavee, which will is expected to reach consumers in the first quarter of 2014, also protects bone density in post-menopausal women. Nausea, diarrhea, abdominal pain and muscle spasms are among the side effects attributed to the drug.

A number of other treatments already exist to combat the effects of hot flashes, including Evista from Eli Lilly (LLY) and Brisdelle from Hisamitsu Pharmaceutical. Evista accounted for $1 billion in sales last year.

Shares of Pfizer dipped slightly in Friday morning trading, while Ligand Pharmaceutical rose modestly.


Article printed from InvestorPlace Media, https://investorplace.com/2013/10/fda-approves-new-hot-flash-treatment-for-menopause/.

©2021 InvestorPlace Media, LLC